C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 20.5 NOK 2.5% Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Carasent ASA
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carasent ASA
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Cash Equivalents
kr375.7m
CAGR 3-Years
-8%
CAGR 5-Years
120%
CAGR 10-Years
40%
N
Nordhealth AS
OSE:NORDH
Cash Equivalents
€17.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Cash Equivalents
kr117.1m
CAGR 3-Years
-27%
CAGR 5-Years
49%
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
19.95 NOK
Overvaluation 3%
Intrinsic Value
Price
C

See Also

What is Carasent ASA's Cash Equivalents?
Cash Equivalents
375.7m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Cash Equivalents amounts to 375.7m NOK.

What is Carasent ASA's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
40%

Over the last year, the Cash Equivalents growth was -43%. The average annual Cash Equivalents growth rates for Carasent ASA have been -8% over the past three years , 120% over the past five years , and 40% over the past ten years .

Back to Top